Hormonal Contraceptives Market to Reach $15.53 Billion by 2029 | Key Drivers and Future Outlook
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#What Is the Growth Rate of the Hormonal Contraceptives Market?#_x000D_
In the past few years, the market size of hormonal contraceptives has seen a slight expansion. An increase from $14.16 billion in 2024 to $14.43 billion in 2025 is expected, translating to a compound annual growth rate (CAGR) of 1.9%. Factors like government policies, rise in contraceptive usage, escalation in pharmaceutical research and development spending, amplified healthcare costs, and the surge in the count of healthcare facilities are responsible for the growth during the historical period._x000D_
_x000D_
#What Growth Rate Is Forecasted for the Hormonal Contraceptives Market by 2029?#_x000D_
It is anticipated that the hormonal contraceptives market will experience slight expansion in the coming years, with a projection to reach $15.53 billion in 2029 and a compound annual growth rate (CAGR) of 1.9%. Factors driving growth over the forecast period include heightened awareness around family planning, increased spending on research and development, a surge in healthcare expenditure, and enhanced collaborations between agencies. Key trends for the forecast period comprise investments in long-lasting vaginal rings, incorporation of AI solutions for improved medication adherence, launch of innovative new products, commitment to environmentally friendly estrogen profiles, advancements in progestogen only birth control pills, and continuous investment in long-term drug delivery systems._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=2440&type=smp_x000D_
_x000D_
#Which Key Companies Are Shaping the Future of the Hormonal Contraceptives Market?#_x000D_
Major companies operating in the hormonal contraceptives market include Bayer AG, Merck & Co. Inc, Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Famy care, Mylan Laboratories_x000D_
_x000D_
#Which Factors Are Driving Demand in the Hormonal Contraceptives Industry?#_x000D_
Rising awareness around hormonal contraceptives has led to a more knowledgeable and self-empowered populace, facilitating individual choices that correspond with their reproductive aims and lifestyle. As people grow more educated about contraceptive methods, they are enabled to make improved decisions regarding their reproductive wellbeing, which subsequently results in a rise in adoption of hormonal contraceptives aligning with their family planning and lifestyle choices. For example, the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations which oversees international public health, reported in September 2023 that in 2022, the worldwide prevalence of any method of contraception reached an estimated 65%. At the same time, the prevalence of modern contraceptive methods was marked at 58.7% among women who are married or in a union. In 2022, the global satisfaction rate among women aged 15 – 49 using modern methods of family planning will hit 77.5%. The hormonal contraceptives market greatly benefits from the heightened awareness of contraceptive benefits and usage._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=2440&type=smp_x000D_
_x000D_
#How Is the Hormonal Contraceptives Market Segmented by Several Divisions?#_x000D_
The hormonal contraceptives market covered in this report is segmented –_x000D_
_x000D_
1) By Product : Pills, Injectable Birth Control, Vaginal Rings, Others_x000D_
2) By End User : Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers_x000D_
3) By Hormones : Progestin-Only, Combined Hormones_x000D_
4) By Distribution Channel : Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels_x000D_
_x000D_
Subsegments:_x000D_
1) By Pills: Combined Oral Contraceptives (COCs), Progestin-Only Pills (POPs), Emergency Contraceptive Pills_x000D_
2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA), Combination Injectable Contraceptives, Subdermal Implants_x000D_
3) By Vaginal Rings: NuvaRing, Annovera, Other Hormonal Vaginal Rings_x000D_
4) By Others: Transdermal Patches, Intrauterine Devices (IUDs) with Hormones, Hormonal Implants, Contraceptive Tablets For Men_x000D_
_x000D_
#What are the Emerging Market Trends Driving the Growth of the Hormonal Contraceptives Industry?#_x000D_
Businesses are pioneering the production of chewable, low-dose oral contraceptives aimed at minimizing side effects. The drive towards chewable contraceptives aims to mitigate adverse side effects and facilitate a daily intake routine for patients. These contraceptive pills are already accessible as over-the-counter products. Notable companies such as Lupin Pharmaceuticals, Walter Chilcott, and Watson Pharmaceuticals are some of the leading producers and suppliers of these chewable, low-dose oral contraceptives._x000D_
_x000D_
#Access The Full Report Here:#_x000D_
_x000D_
#Which Regions Are Driving Growth in the Hormonal Contraceptives Market?#_x000D_
North America was the largest region in the hormonal contraceptives market share in 2024. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_
_x000D_
#Purchase The Full Report Today:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2440_x000D_
_x000D_
#This Report Delivers Insight On: #_x000D_
1. How big is the hormonal contraceptives market, and how is it changing globally?_x000D_
2. Who are the major companies in the hormonal contraceptives market, and how are they performing?_x000D_
3. What are the key opportunities and risks in the hormonal contraceptives market right now?_x000D_
4. Which products or customer segments are growing the most in the hormonal contraceptives market?_x000D_
5. What factors are helping or slowing down the growth of the hormonal contraceptives market?_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 2071930708_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
